In vitro experiments and animal models using specific COX-2 inhibitors show a reduction in proliferation and invasion of breast cancer cells and an effect on tumor development and growth (Bocca et al. 2011; Na et al. 2013; Silva et al. 2012). This evidence concerns the gene PTGS2 and neoplasm.